Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-006150
Filing Date
2010-02-02
Accepted
2010-02-02 20:46:54
Documents
1
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 rrd264330.html 5  
1 FORM 5 rrd264330.xml 5 6175
  Complete submission text file 0001181431-10-006150.txt   7892
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Issuer) CIK: 0000849636 (see all company filings)

EIN.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92618
Business Address
Johnson Steven Andrew (Reporting) CIK: 0001389221 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-16467 | Film No.: 10568658